Evidence map›Paper›PMID 26363376›Full record

ArticleActa biomaterialia2015

Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications.

Sheng Feng, Yu Zhao, Ming Xian, Qian Wang

Abstract read
In one paragraph

Article in Acta biomaterialia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 73 citations in OpenAlex.

  1. Therapeutic Gases in Biomedicine: Updates on Nitric Oxide and Beyond.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Controlled Release of HBiomacromolecules · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.Advances in experimental medicine and biology · 2021
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Hydrogen Sulfide as Potential RegulatoryInternational journal of molecular sciences · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sheng FengDepartment of Chemistry and Biochemistry and Nanocenter, University of South Carolina, Columbia, SC 29208, USA.
Yu ZhaoDepartment of Chemistry, Washington State University, Pullman, WA 99164, USA.
Ming XianDepartment of Chemistry, Washington State University, Pullman, WA 99164, USA. Electronic address: mxian@wsu.edu.
Qian WangDepartment of Chemistry and Biochemistry and Nanocenter, University of South Carolina, Columbia, SC 29208, USA. Electronic address: wang263@mailbox.sc.edu.
Washington State University · USUniversity of South Carolina · US

Funding

Novel Sulfide Releasing Agents for Ischemic InjuryR01HL116571 · NHLBI · WASHINGTON STATE UNIVERSITY · PI LEFER, DAVID JOSEPH, XIAN, MING · 2014 to 2017
$1.8M
NHLBI NIH HHS R01 HL116571NHLBI NIH HHS R01HL116571
6 · The paper itself

Abstract

By electrospinning of polycaprolactone (PCL) solutions containing N-(benzoylthio)benzamide (NSHD1), a H2S donor, fibrous scaffolds with hydrogen sulfide (H2S) releasing capability (H2S-fibers) are fabricated. The resultant microfibers are capable of releasing H2S upon immersion in aqueous solution containing biological thiols under physiological conditions. The H2S release peaks of H2S-fibers appeared at 2-4h, while the peak of donor alone showed at 45 min. H2S release half-lives of H2S-fibers were 10-20 times longer than that of donor alone. Furthermore, H2S-fibers can protect cells from H2O2 induced oxidative damage by significantly decreasing the production of intracellular reactive oxygen species (ROS). Finally, we investigated the H2S-fibers application as a wound dressing in vitro. Given that H2S has a broad range of physiological functions, H2S-fibers hold great potential for various biomedical applications. STATEMENT OF SIGNIFICANCE: Hydrogen sulfide, as a gaseous messenger, plays a crucial role in many physiological and pathological conditions. Recent studies about functions of H2S suggests H2S-based therapy could be promising therapeutic strategy for many diseases, such as cardiovascular disease, arthritis, and inflammatory bowel disease. Although many H2S donors have been developed and applied for biomedical studies, most of H2S donors have the shortage that the H2S release is either too fast or uncontrollable, which poorly mimic the biological generation of H2S. By simply combining electrospinning technique with our designed biological thiols activated H2S donor, NSHD1, we fabricated H2S releasing microfibers (H2S-fibers). This H2S-fibers significantly prolonged the releasing time compared to H2S donor alone. By adjusting the electrospinning parameters, tunable releasing profiles can be achieved. Moreover, the H2S fibers can protect cardiac myoblasts H9c2 and fibroblast NIH 3T3 from oxidative damage and support their proliferation as cellular scaffolds. To our knowledge, this is the first report of electrospun fibers with H2S releasing capacity. We anticipate this H2S-releasing scaffold will have great potential for biomedical applications.

Indexed as

BandagesAbsorption, PhysicochemicalAnimalsBiological ProductsCell SurvivalDelayed-Action PreparationsDiffusionEquipment DesignHydrogen SulfideMaterials TestingMiceNanofibersNIH 3T3 CellsParticle SizePolyestersRatsBiological ProductsDelayed-Action PreparationsHydrogen SulfidepolycaprolactonePolyestersSulfhydryl CompoundsControlled releaseElectrospinningHydrogen sulfideIschemia reperfusion injuryNSHD1

Identifiers

PMID26363376
PMCPMC4609630
OpenAlexW1412109522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.